2BB score and signals
Outlook Therapeutics, Inc.’s current 2BB score is 54 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 75 | High |
| Momentum | 80 | Improving |
| Financial strength | 0 | Very Weak |
| Quality | 47 | Normal |
| Risk | 71 | High |
Company facts
| Founded | 2010 |
| Employees | 17 |
| 52-week range | $0.16 – $2.54 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-15 | — | -0.051 | — | $5.59M |
| 2026-12-17 | — | -0.0612 | — | $4.20M |
| 2026-08-14 | -0.09 | -0.0952 | $10,000.00 | $5.41M |
| 2026-05-15 | -0.16 | -0.1224 | $128,000.00 | $4.49M |
Related companies
